Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2010
12/30/2010US20100331407 Clear ophthalmic solution comprising latanoprost as active ingredient
12/30/2010US20100331396 Neostatins
12/30/2010US20100331395 Decoy-containing pharmaceutical compositions and method of using the same
12/30/2010US20100331394 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure
12/30/2010US20100331384 Guanidine based compounds
12/30/2010US20100331322 Substituted piperidines as renin inhibitors
12/30/2010US20100331311 Galantamine as a neuroprotective drug for retinal ganglion cells
12/30/2010US20100331304 Compounds Which Modulate The CB2 Receptor
12/30/2010US20100331289 Combination of Azelastine and Steroids
12/30/2010US20100330673 Methods of making enhanced, autologous fat grafts
12/30/2010US20100330171 Dietary Supplement for Eye Health
12/30/2010US20100330164 Method of increasing tear production with purinergic receptor agonists
12/30/2010US20100330146 Contact lenses for extended release of bioactive agents containing diffusion attenuators
12/30/2010US20100330097 Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
12/30/2010US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
12/30/2010US20100330042 Use of Proinsulin for the Preparation of a Neuroprotective Pharmaceutical Composition, Therapeutic Composition Containing it and Applications Thereof
12/29/2010WO2010150899A1 Novel thiophene carboxamide derivative and medicinal use of same
12/29/2010WO2010150840A1 N-substituted-cyclic amino derivative
12/29/2010WO2010150812A1 Ophthalmic composition and method for prevention of cloudiness/precipitation
12/29/2010WO2010150564A1 Benzaldehyde compound
12/29/2010WO2010150400A1 Jelly preparation containing isosorbide
12/29/2010WO2010150378A1 Ophthalmic composition
12/29/2010WO2010149281A1 Use of cd44v6 in the treatment of ophthalmic diseases
12/29/2010WO2010149044A1 Micromolecular benzotriazine compounds, compositions and uses thereof
12/29/2010EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject
12/29/2010EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267010A2 Activatable recombinant neurotoxins
12/29/2010EP2267009A2 Activatable recombinant neurotoxins
12/29/2010EP2267008A2 Activatable recombinant neurotoxins
12/29/2010EP2266978A1 Novel physiologically active substances
12/29/2010EP2266968A2 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
12/29/2010EP2266960A2 Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266593A1 Use of CD44v6 in the treatment of ophthalmic diseases
12/29/2010EP2266559A1 Therapeutic agent for ophthalmic disease
12/29/2010EP2265591A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
12/29/2010EP2265266A2 Vitamin d compounds and methods for reducing ocular hypertension (oht)
12/29/2010EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
12/29/2010EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010EP1183022B1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
12/29/2010CN1989439B Methods and compositions for the treatment of uveitis
12/29/2010CN1824063B Medicine and food dual purpose Chinese and western medicine combined product for preventing and trecting pseudomyopia
12/29/2010CN101932586A Inhibitors of protein tyrosine kinase activity
12/29/2010CN101932575A Piperidine derivative
12/29/2010CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
12/29/2010CN101928262A Biologically active methylene blue derivatives
12/29/2010CN101926985A Lumbrokinase injection for treating thromboembolic disease
12/29/2010CN101926890A Medicament for treating xerophthalmia
12/29/2010CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material
12/29/2010CN101926788A Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof
12/29/2010CN101926762A Rupatadine fumarate eye drops and preparation method thereof
12/29/2010CN101926760A Dexamethasone injecta coated with 2-hydroxypropyl-beta-cyclodextrin
12/29/2010CN101926464A Preparation method of medicament vinegar egg
12/29/2010CN101926396A Method for preparing Chinese medicinal bagged tea
12/29/2010CN101530489B Chinese medicine composition used for treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy and preparation method thereof
12/29/2010CN101445504B Dioxane-2-alkyl carbamates derivatives
12/29/2010CN101406596B Medicament for treating dry eye
12/29/2010CN101390825B Intra-ocular release system of voriconazole
12/29/2010CN101098702B Drugs, food or drink for improving pancreatic functions
12/29/2010CA2781771A1 Method for treatment of diseases
12/29/2010CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them
12/28/2010US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
12/28/2010US7858346 Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein
12/28/2010US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
12/23/2010WO2010148352A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
12/23/2010WO2010147133A1 Novel imidazopyridine compound
12/23/2010WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor
12/23/2010WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof
12/23/2010WO2010146881A1 Substituted isoquinoline derivative
12/23/2010WO2010146460A1 Methods of treating outer eye disorders using high orp acid water and compositions thereof
12/23/2010WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators
12/23/2010WO2010146150A1 Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
12/23/2010WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof
12/23/2010WO2010126626A3 Dual mechanism inhibitors for the treatment of disease
12/23/2010WO2010056598A3 Biodegradable alpha-2 adrenergic agonist polymeric implants
12/23/2010US20100324151 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
12/23/2010US20100324138 Lipoxin A4 Protection for Retinal Cells
12/23/2010US20100324104 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/23/2010US20100324084 Urea derivatives of tropane, their preparation and their therapeutic application
12/23/2010US20100324071 Novel glucokinase activators and methods of using same
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324031 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010US20100324005 Method for treatment of diseases
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100324000 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptors
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323992 Pharmaceutical compositions for preventing and treating eye pathologies
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323978 Non-aqueous oil delivery system for ophthalmic drugs
12/23/2010US20100323970 Sap variants and their use
12/23/2010US20100323964 New non-selective somatostatin analogues
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 531